Search by Drug Name or NDC

NDC 00143-9151-10 Dihydroergotamine Mesylate 1 mg/mL Details

Dihydroergotamine Mesylate 1 mg/mL

Dihydroergotamine Mesylate is a INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is DIHYDROERGOTAMINE MESYLATE.

MedlinePlus Drug Summary

Dihydroergotamine is used to treat migraine headaches (severe, throbbing headaches that sometimes are accompanied by nausea and sensitivity to sound and light) and cluster headaches (severe headaches usually on one side of the head or around one eye). Dihydroergotamine is in a class of medications called ergot alkaloids. It works by tightening blood vessels in the brain and by stopping the release of natural substances in the brain that cause swelling.

Related Packages: 00143-9151-10
Last Updated: 03/24/2024
MedLinePlus Full Drug Details: Dihydroergotamine Injection

Product Information

NDC	00143-9151
Product ID	0143-9151_d2a5e902-dbcc-4e9e-9963-aba4568e2835
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Dihydroergotamine Mesylate
Proprietary Name Suffix	n/a
Non-Proprietary Name	Dihydroergotamine Mesylate
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	INJECTION
Route	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
Active Ingredient Strength	1
Active Ingredient Units	mg/mL
Substance Name	DIHYDROERGOTAMINE MESYLATE
Labeler Name	Hikma Pharmaceuticals USA Inc.
Pharmaceutical Class	Ergotamine Derivative [EPC], Ergotamines [CS]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA040453
Listing Certified Through	2024-12-31

Package

NDC 00143-9151-10 (00143915110)

Pricing Information	N/A
NDC Package Code	0143-9151-10
Billing NDC	00143915110
Package	10 VIAL in 1 CARTON (0143-9151-10) / 1 mL in 1 VIAL
Marketing Start Date	2023-03-31
NDC Exclude Flag	N